1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. Qiagen N.V.
  6. News
  7. Summary
    QGEN   NL0012169213

QIAGEN N.V.

(QGEN)
  Report
Real-time Estimate Cboe BZX  -  05/19 02:41:24 pm EDT
44.74 USD   +1.76%
05/16QIAGEN NV : Berenberg keeps its Buy rating
MD
05/16QIAGEN Expands Syndromic Testing Portfolio with the Launch of Higher-Capacity QIAstat-Dx Rise and Enhanced Panels
BU
05/16QIAGEN Expands Syndromic Testing Portfolio with the Launch of Higher-Capacity QIAstat-Dx Rise and Enhanced Panels
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

QIAGEN NV : DZ Bank takes a positive view

01/17/2022 | 02:57am EDT

DZ Bank's analyst Sven Kürten upgrades his rating from Neutral to Buy.


© MarketScreener with dpa-AFX Analyser 2022
All news about QIAGEN N.V.
05/16QIAGEN NV : Berenberg keeps its Buy rating
MD
05/16QIAGEN Expands Syndromic Testing Portfolio with the Launch of Higher-Capacity QIAstat-D..
BU
05/16QIAGEN Expands Syndromic Testing Portfolio with the Launch of Higher-Capacity QIAstat-D..
CI
05/11SECTOR UPDATE : Health Care Stocks Edging Lower Ahead of Wednesday Close
MT
05/11SECTOR UPDATE : Health Care Stocks Still Hanging on for Small Advance
MT
05/11Qiagen to Acquire 96% Stake In BLIRT for Undisclosed Sum
MT
05/11QIAGEN Acquires Majority Stake in Enzymes Provider BLIRT S.A.
BU
05/11QIAGEN Proposes Expansion of Supervisory Board
BU
05/11Qiagen N.V. agreed to acquire 96.3% stake in BLIRT S.A. from N50 Cyprus Limited, Marian..
CI
05/10TRANSCRIPT : QIAGEN N.V. Presents at Bank of America 2022 Healthcare Conference, May-10-20..
CI
More news
Analyst Recommendations on QIAGEN N.V.
More recommendations
Financials (USD)
Sales 2022 2 093 M - -
Net income 2022 387 M - -
Net Debt 2022 497 M - -
P/E ratio 2022 25,7x
Yield 2022 -
Capitalization 9 999 M 9 999 M -
EV / Sales 2022 5,02x
EV / Sales 2023 4,69x
Nbr of Employees 6 000
Free-Float 98,2%
Chart QIAGEN N.V.
Duration : Period :
Qiagen N.V. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends QIAGEN N.V.
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 13
Last Close Price 43,96 $
Average target price 56,32 $
Spread / Average Target 28,1%
EPS Revisions
Managers and Directors
Thierry Bernard Chief Executive Officer & Managing Director
Roland Sackers Vice President-Finance
Lawrence A. Rosen Chairman-Supervisory Board
Barthold Piening Senior Vice President & Head-Global Operations
Lezette Young Manager-Compliance & Legal
Sector and Competitors
1st jan.Capi. (M$)
QIAGEN N.V.-20.91%9 999
MODERNA, INC.-45.78%54 775
LONZA GROUP AG-29.81%40 137
IQVIA HOLDINGS INC.-30.08%37 337
SEAGEN INC.-7.50%26 323
ICON PUBLIC LIMITED COMPANY-34.37%16 524